A detailed history of Howard Marks (Oaktree Capital Management LP) transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Oaktree Capital Management LP holds 3,245,439 shares of BLCO stock, worth $50.6 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
3,245,439
Previous 2,521,245 28.72%
Holding current value
$50.6 Million
Previous $32.8 Million 49.11%
% of portfolio
1.24%
Previous 0.89%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$13.45 - $15.52 $9.74 Million - $11.2 Million
724,194 Added 28.72%
3,245,439 $48.9 Million
Q2 2025

Aug 13, 2025

BUY
$10.9 - $14.35 $27.5 Million - $36.2 Million
2,521,245 New
2,521,245 $32.8 Million

Others Institutions Holding BLCO

About Bausch & Lomb Corp


  • Ticker BLCO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 350,000,000
  • Market Cap $5.46B
  • Description
  • Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...
More about BLCO
Track Howard Marks's Portfolio

Track Howard Marks Portfolio

Follow Howard Marks (Oaktree Capital Management LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oaktree Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Oaktree Capital Management LP and Howard Marks with notifications on news.